Literature DB >> 15469994

Design of fully active FGF-1 variants with increased stability.

Malgorzata Zakrzewska1, Daniel Krowarsch, Antoni Wiedlocha, Jacek Otlewski.   

Abstract

Fibroblast growth factor 1 is a powerful mitogen playing an important role in morphogenesis, angiogenesis and wound healing and is therefore of potential medical interest. Using homologous sequence and structure comparisons, we designed and constructed 16 mutants of FGF-1 with increased thermodynamic stability, as determined by chemical and heat denaturation. For multiple mutants, additive effects on stability were observed, providing mutants up to 7.8 degrees C more stable than the wild-type. None of the introduced mutations affected any FGF-1 biological activities, such as stimulation of DNA synthesis, MAP kinase activation and binding to the FGF receptor on the cell surface. Our study provides a good starting point to improve the stability of FGF-1 in the context of its wide potential therapeutic applications. We showed that a homology approach is an effective method to change the thermodynamic properties of the protein without altering its function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469994     DOI: 10.1093/protein/gzh076

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  14 in total

1.  Instability restricts signaling of multiple fibroblast growth factors.

Authors:  Marcela Buchtova; Radka Chaloupkova; Malgorzata Zakrzewska; Iva Vesela; Petra Cela; Jana Barathova; Iva Gudernova; Renata Zajickova; Lukas Trantirek; Jorge Martin; Michal Kostas; Jacek Otlewski; Jiri Damborsky; Alois Kozubik; Antoni Wiedlocha; Pavel Krejci
Journal:  Cell Mol Life Sci       Date:  2015-02-18       Impact factor: 9.261

2.  Probing the role of proline -135 on the structure, stability, and cell proliferation activity of human acidic fibroblast growth factor.

Authors:  Julie Eberle Davis; Arwa Alghanmi; Ravi Kumar Gundampati; Srinivas Jayanthi; Ellen Fields; Monica Armstrong; Vanessa Weidling; Varun Shah; Shilpi Agrawal; Bhanu Prasanth Koppolu; David A Zaharoff; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  Arch Biochem Biophys       Date:  2018-07-19       Impact factor: 4.013

Review 3.  Protein engineering for cardiovascular therapeutics: untapped potential for cardiac repair.

Authors:  Steven M Jay; Richard T Lee
Journal:  Circ Res       Date:  2013-09-13       Impact factor: 17.367

4.  A study of the activity and effectiveness of recombinant fibroblast growth factor (Q40P/S47I/H93G rFGF-1) in anti-aging treatment.

Authors:  Justyna Żerańska; Monika Pasikowska; Barbara Szczepanik; Krzysztof Mlosek; Sylwia Malinowska; Renata M Dębowska; Irena Eris
Journal:  Postepy Dermatol Alergol       Date:  2016-02-29       Impact factor: 1.837

5.  Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity.

Authors:  Julia Chudzian; Anna Szlachcic; Malgorzata Zakrzewska; Miroslawa Czub; Marcin Pustula; Tad A Holak; Jacek Otlewski
Journal:  Int J Mol Sci       Date:  2018-08-21       Impact factor: 5.923

6.  Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.

Authors:  Malgorzata Zakrzewska; Antoni Wiedlocha; Anna Szlachcic; Daniel Krowarsch; Jacek Otlewski; Sjur Olsnes
Journal:  J Biol Chem       Date:  2009-07-02       Impact factor: 5.157

7.  FGF1-gold nanoparticle conjugates targeting FGFR efficiently decrease cell viability upon NIR irradiation.

Authors:  Anna Szlachcic; Katarzyna Pala; Malgorzata Zakrzewska; Piotr Jakimowicz; Antoni Wiedlocha; Jacek Otlewski
Journal:  Int J Nanomedicine       Date:  2012-11-29

8.  Antibody-induced dimerization of FGFR1 promotes receptor endocytosis independently of its kinase activity.

Authors:  Łukasz Opaliński; Aleksandra Sokołowska-Wędzina; Martyna Szczepara; Małgorzata Zakrzewska; Jacek Otlewski
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379

9.  Effect of extension of the heparin binding pocket on the structure, stability, and cell proliferation activity of the human acidic fibroblast growth factor.

Authors:  Julie Eberle Davis; Ravi Kumar Gundampati; Srinivas Jayanthi; Joshua Anderson; Abigail Pickhardt; Bhanu Prasanth Koppolu; David A Zaharoff; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  Biochem Biophys Rep       Date:  2017-12-22

10.  High Affinity Promotes Internalization of Engineered Antibodies Targeting FGFR1.

Authors:  Łukasz Opaliński; Jakub Szymczyk; Martyna Szczepara; Marika Kucińska; Daniel Krowarsch; Małgorzata Zakrzewska; Jacek Otlewski
Journal:  Int J Mol Sci       Date:  2018-05-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.